title: Acute pancreatitis associated with lamivudine therapy for chronic B hepatitis.
abstract: Hyperamylasemia is a common complication during lamivudine use. We report a case of a pancreatitis following lamivudine therapy. A careful monitoring of amylase levels during treatment with lamivudine is discussed, mainly in the first weeks, considering the cost of this exam and further complication.
authors.affiliation: Department of Infectious Diseases, University of São Paulo, Medical School, São Paulo, SP, Brazil. ffbt@pop.com.br
authors.forename: Felipe Francisco
authors.initials: FF
authors.lastname: Tuon
authors.forename: Cristina Maria de Fátima
authors.initials: CM
authors.lastname: Guastini
authors.forename: Maria Ivete Castro
authors.initials: MI
authors.lastname: Boulos
mesh_terms: D000208:Acute Disease; D019694:Hepatitis B, Chronic / Q000188:drug therapy; D006801:Humans; D034321:Hyperamylasemia / Q000139:chemically induced*; D019259:Lamivudine / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010195:Pancreatitis / Q000139:chemically induced* / Q000201:enzymology; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine